Anti-GLB1 / Beta galactosidase, clone 25G11

Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA. GLB1 (Beta-galactosidase) is a lysosomal hydrolase that catalyzes the breakdown of terminal beta-galactosides into monosaccharides. This enzyme is critical for the proper degradation of glycolipids, glycoproteins, and glycosaminoglycans. Researchers commonly use a GLB1 antibody to study lysosomal function and carbohydrate metabolism. Deficiency of GLB1 activity is associated with lysosomal storage disorders such as GM1 gangliosidosis and Morquio B disease. These conditions highlight the importance of GLB1 in cellular homeostasis and human health. Employing a GLB1 antibody enables detection of protein expression and activity in both normal physiology and disease contexts. NSJ Bioreagents provides a high-quality GLB1 antibody validated for applications including western blot, immunohistochemistry, and immunofluorescence. Using a GLB1 antibody ensures sensitive and reproducible results for studies of lysosomal biology, enzymatic function, and inherited metabolic disorders.